
Gustavo A. Rosario Benitez
Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2838 |
| Total Applications | 811 |
| Issued Applications | 625 |
| Pending Applications | 91 |
| Abandoned Applications | 129 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5236513
[patent_doc_number] => 20070128670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/584728
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12824
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584728 | Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof | Dec 22, 2004 | Abandoned |
Array
(
[id] => 7045147
[patent_doc_number] => 20050249742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Compositions and methods for modulating a cytotoxic T lymphocyte immune response'
[patent_app_type] => utility
[patent_app_number] => 11/022562
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14481
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022562 | Compositions and methods for modulating a cytotoxic T lymphocyte immune response | Dec 21, 2004 | Abandoned |
Array
(
[id] => 7193054
[patent_doc_number] => 20050163778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Extracorporeal photopheresis in combination with anti-TNF treatment'
[patent_app_type] => utility
[patent_app_number] => 11/018240
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13140
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163778.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018240 | Extracorporeal photopheresis in combination with anti-TNF treatment | Dec 20, 2004 | Abandoned |
Array
(
[id] => 72174
[patent_doc_number] => 07754853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'TNF alpha-binding polypeptide compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/005726
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 29
[patent_no_of_words] => 16037
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754853.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005726 | TNF alpha-binding polypeptide compositions and methods | Dec 6, 2004 | Issued |
Array
(
[id] => 4523899
[patent_doc_number] => 07951783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Therapeutically useful molecules'
[patent_app_type] => utility
[patent_app_number] => 10/581773
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6266
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581773 | Therapeutically useful molecules | Dec 5, 2004 | Issued |
Array
(
[id] => 5769494
[patent_doc_number] => 20050266004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Anti-human lymphotoxin alpha antibodies, compositions, methods and uses'
[patent_app_type] => utility
[patent_app_number] => 10/999866
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34612
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999866 | Anti-human lymphotoxin alpha antibodies, compositions, methods and uses | Nov 29, 2004 | Abandoned |
Array
(
[id] => 6996226
[patent_doc_number] => 20050136004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Anti-IL-20 antibodies and binding partners and methods of using in inflammation'
[patent_app_type] => utility
[patent_app_number] => 10/994116
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70921
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994116 | Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies | Nov 18, 2004 | Issued |
Array
(
[id] => 4484514
[patent_doc_number] => 07883703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Methods of modulating immunity'
[patent_app_type] => utility
[patent_app_number] => 10/987380
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 19170
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/883/07883703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987380
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987380 | Methods of modulating immunity | Nov 11, 2004 | Issued |
Array
(
[id] => 5828158
[patent_doc_number] => 20060063235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'DNA encoding the human serine protease C-E'
[patent_app_type] => utility
[patent_app_number] => 10/988164
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17104
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988164 | DNA encoding the human serine protease C-E | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5894396
[patent_doc_number] => 20060002935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 10/985847
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 62908
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985847 | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor | Nov 9, 2004 | Abandoned |
Array
(
[id] => 7159617
[patent_doc_number] => 20050084493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/985299
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20753
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985299 | Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof | Nov 8, 2004 | Abandoned |
Array
(
[id] => 6906375
[patent_doc_number] => 20050101770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Interleukin-10 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/985584
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21773
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985584 | Interleukin-10 antibodies | Nov 8, 2004 | Abandoned |
Array
(
[id] => 6939131
[patent_doc_number] => 20050112694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Antibodies that bind interleukin-4 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/982359
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 40392
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982359 | Antibodies that bind interleukin-4 receptor | Nov 3, 2004 | Abandoned |
Array
(
[id] => 5084945
[patent_doc_number] => 20070274996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Antibodies That Bind Interleukin-4 Receptor'
[patent_app_type] => utility
[patent_app_number] => 10/578410
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 40389
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578410 | Antibodies that bind interleukin-4 receptor | Nov 3, 2004 | Issued |
Array
(
[id] => 7176147
[patent_doc_number] => 20050123542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Methods for treating disorders involving monocytes'
[patent_app_type] => utility
[patent_app_number] => 10/982725
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7325
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982725 | Methods for treating disorders involving monocytes | Nov 3, 2004 | Abandoned |
Array
(
[id] => 7182847
[patent_doc_number] => 20050191309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Induction of antigen specific immunologic tolerance'
[patent_app_type] => utility
[patent_app_number] => 10/980648
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21635
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980648 | Induction of antigen specific immunologic tolerance | Nov 2, 2004 | Abandoned |
Array
(
[id] => 5100774
[patent_doc_number] => 20070184036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Isolated cd4+ t cells defined by cmrf-35'
[patent_app_type] => utility
[patent_app_number] => 10/577627
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27429
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577627 | Isolated cd4+ t cells defined by cmrf-35 | Oct 27, 2004 | Abandoned |
Array
(
[id] => 7127331
[patent_doc_number] => 20050059075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Isolated human zinc metalloprotease, nucleic acid molecules encoding said enzymes, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/971008
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20224
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971008
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971008 | Isolated human zinc metalloprotease, nucleic acid molecules encoding said enzymes, and uses thereof | Oct 24, 2004 | Abandoned |
Array
(
[id] => 6912270
[patent_doc_number] => 20050176028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Deimmunized binding molecules to CD3'
[patent_app_type] => utility
[patent_app_number] => 10/966406
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 9783
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966406 | Deimmunized binding molecules to CD3 | Oct 14, 2004 | Abandoned |
Array
(
[id] => 7005691
[patent_doc_number] => 20050171004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Use of cardiotrophin-1 to promote wound healing and counteract overt fibrosis'
[patent_app_type] => utility
[patent_app_number] => 10/954159
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 10650
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10954159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/954159 | Use of cardiotrophin-1 to promote wound healing and counteract overt fibrosis | Sep 29, 2004 | Abandoned |